Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crystallizing thinking about the beta2-adrenergic receptor.

Arun K Shukla1, Jin-Peng Sun, Robert J Lefkowitz

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Molecular Pharmacology
|February 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

Trends in cell biology·2026
Same author

Small-molecule modulation of β-arrestins.

Nature·2026
Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026
Same author

Q&A with Arun K. Shukla.

Cell reports·2026
Same author

Cryo-EM structures of GPR133 from basal organisms elucidate evolutionary conservation and divergence of its activation.

Biochemical and biophysical research communications·2026
Same author

β-Arrestin condensates regulate G-protein-coupled receptor function.

Nature·2026
Same journal

Regulation of organic anion transporting polypeptide 1B1 transport function by lysine deacetylase 6.

Molecular pharmacology·2026
Same journal

Neuroprotective in vitro effects of histone deacetylase 6-selective inhibitor SW-100 toward oxaliplatin-derived toxicity.

Molecular pharmacology·2026
Same journal

Emerging roles of platelet DNA in cancer detection and noninvasive prenatal testing.

Molecular pharmacology·2026
Same journal

Binding affinities for histamine receptors 1 to 4: Systematic comparison of ligands from the Psychoactive Drug Screening Program K<sub>i</sub> database and International Union of Basic and Clinical Pharmacology/British Pharmacological Society Guide to Pharmacology.

Molecular pharmacology·2026
Same journal

Molecular pharmacology of mGlu<sub>7/8</sub> heterodimers reveals unique properties of orthosteric agonists and positive allosteric modulators.

Molecular pharmacology·2026
Same journal

Effects of ivermectin on the activation and desensitization of the human GABA<sub>A</sub> receptor.

Molecular pharmacology·2026
See all related articles

Crystal structures of the human beta2-adrenergic receptor (beta2AR) offer a breakthrough in G protein-coupled receptor research. These findings advance our understanding of this crucial receptor family.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • G protein-coupled receptors (GPCRs) represent the largest membrane receptor family in the human genome.
  • The human beta2-adrenergic receptor (beta2AR) is a key target for numerous therapeutics.
  • Previous structural determination of rhodopsin paved the way for GPCR structural studies.

Purpose of the Study:

  • To present and analyze the recently determined crystal structures of the human beta2-adrenergic receptor (beta2AR).
  • To provide historical context for GPCR structural biology advancements.
  • To critically evaluate the knowledge gained and remaining challenges in beta2AR research.

Main Methods:

  • X-ray crystallography was employed to determine the beta2AR structures.

Related Experiment Videos

  • Comparative analysis with existing GPCR structures (e.g., rhodopsin) was performed.
  • Literature review and expert appraisal of the findings were conducted.

    • Main Results:

    • The crystal structures of the beta2AR, only the second GPCR structure solved after rhodopsin, have been determined.
    • These structures offer unprecedented atomic-level insights into beta2AR conformation and function.
    • Significant challenges in GPCR structural determination have been overcome.

    Conclusions:

    • The solved beta2AR structures represent a major leap forward in understanding GPCRs.
    • These findings facilitate structure-based drug design and therapeutic development targeting beta2AR.
    • Further research is needed to fully elucidate all functional aspects and signaling mechanisms.